| Primary |
| Glaucoma |
44.4% |
| Dry Eye |
18.5% |
| Intraocular Pressure Increased |
18.5% |
| Product Used For Unknown Indication |
7.4% |
| Blindness |
3.7% |
| Off Label Use |
3.7% |
| Retinal Haemorrhage |
3.7% |
|
| Eye Irritation |
14.3% |
| Anaphylactic Reaction |
9.5% |
| Ocular Hyperaemia |
9.5% |
| Product Substitution Issue |
9.5% |
| Eye Swelling |
4.8% |
| Hyphaema |
4.8% |
| Instillation Site Pain |
4.8% |
| Intraocular Pressure Increased |
4.8% |
| Lacrimation Increased |
4.8% |
| Polyneuropathy |
4.8% |
| Post Procedural Complication |
4.8% |
| Product Dropper Issue |
4.8% |
| Product Packaging Quantity Issue |
4.8% |
| Product Quality Issue |
4.8% |
| Pruritus |
4.8% |
| Visual Acuity Reduced |
4.8% |
|
| Secondary |
| Glaucoma |
24.3% |
| Intraocular Pressure Increased |
21.6% |
| Dry Eye |
10.8% |
| Open Angle Glaucoma |
7.2% |
| Bacteraemia |
5.4% |
| Hypertension |
4.5% |
| Eye Operation |
2.7% |
| Off Label Use |
2.7% |
| Retinal Haemorrhage |
2.7% |
| Anaesthesia |
1.8% |
| Anterior Chamber Disorder |
1.8% |
| Depression |
1.8% |
| Hypertonia |
1.8% |
| Intraocular Pressure Test |
1.8% |
| Ocular Hypertension |
1.8% |
| Product Used For Unknown Indication |
1.8% |
| Prophylaxis |
1.8% |
| Type 2 Diabetes Mellitus |
1.8% |
| Bronchitis Chronic |
0.9% |
| Developmental Glaucoma |
0.9% |
|
| Intraocular Pressure Increased |
14.3% |
| Blepharitis |
8.6% |
| Conjunctivitis |
8.6% |
| Lacrimation Increased |
8.6% |
| Choroidal Haemorrhage |
5.7% |
| Nausea |
5.7% |
| Oesophageal Carcinoma |
5.7% |
| Visual Acuity Reduced |
5.7% |
| Vitreous Detachment |
5.7% |
| Condition Aggravated |
2.9% |
| Corneal Oedema |
2.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.9% |
| Eye Swelling |
2.9% |
| Foetal Growth Restriction |
2.9% |
| Hyphaema |
2.9% |
| Product Quality Issue |
2.9% |
| Product Substitution Issue |
2.9% |
| Skin Irritation |
2.9% |
| Throat Irritation |
2.9% |
| Toxic Epidermal Necrolysis |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.2% |
| Glaucoma |
14.7% |
| Drug Use For Unknown Indication |
12.1% |
| Bacteraemia |
11.9% |
| Hypertension |
9.7% |
| Depression |
5.0% |
| Type 2 Diabetes Mellitus |
5.0% |
| Pneumonia |
2.8% |
| Toxic Epidermal Necrolysis |
2.4% |
| Cerebrovascular Accident Prophylaxis |
2.0% |
| Ocular Hypertension |
2.0% |
| Atrial Fibrillation |
1.8% |
| Intraocular Pressure Increased |
1.8% |
| Asthma |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Dementia Alzheimer's Type |
1.6% |
| Diabetes Mellitus |
1.6% |
| Osteoporosis |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Hyperlipidaemia |
1.4% |
|
| Intraocular Pressure Increased |
19.7% |
| Toxic Epidermal Necrolysis |
15.2% |
| Anterior Chamber Flare |
4.5% |
| Drug Interaction |
4.5% |
| Duodenal Ulcer Haemorrhage |
4.5% |
| Ocular Discomfort |
4.5% |
| Periarthritis |
4.5% |
| Renal Mass |
4.5% |
| Syncope |
4.5% |
| Abdominal Injury |
3.0% |
| Anterior Chamber Cell |
3.0% |
| Cataract |
3.0% |
| Dizziness |
3.0% |
| Drug Ineffective |
3.0% |
| Hyphaema |
3.0% |
| Hypoglycaemia |
3.0% |
| Iridodialysis |
3.0% |
| Myalgia |
3.0% |
| Myocardial Infarction |
3.0% |
| Neck Pain |
3.0% |
|
